Barthelmes D, et al. - Researchers, herein, focused on 24-month outcomes of a treat and extend (T&E) regimen using aflibercept in eyes with neovascular age-related macular degeneration. Based on the findings, they concluded that good visual outcomes along with the decreased burden of treatments and clinic visits could be achieved as a result of treating eyes with aflibercept, as a sole therapy, in routine clinical practice with a T&E regimen.